HCPCS code P9023 – Solvent/detergent pooled plasma

Key takeaways

HCPCS code P9023 reports solvent/detergent treated plasma, pooled from multiple donors and frozen, billed per unit. Octaplas is the licensed US product.

P9023 is not a general fresh frozen plasma code. Single-donor FFP is P9017, and pathogen-reduced plasma is P9070 (pooled) or P9071 (single donor).

Hospital outpatient departments are paid for P9023 under OPPS with status indicator R. The Medicare blood deductible does not apply to plasma.

Pabau, the practice management platform we build, keeps clinical notes, charges, and claim status in one system. Each P9023 line then traces back to its documentation.

HCPCS code P9023: definition and official descriptor

HCPCS code P9023 is the Level II code for plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit. It sits in the P9010-P9100 blood and blood products range of the CMS HCPCS Level II system. CMS publishes its short descriptor as “Frozen plasma, pooled, sd”, and confirms the code as active in the current CMS HCPCS alpha-numeric file.

The billing unit is one bag of S/D plasma as issued by the blood bank. P9023 is billed by the hospital or facility that furnishes the product, so confirm setting-specific rules with your Medicare Administrative Contractor (MAC).

What is solvent/detergent pooled plasma?

Solvent/detergent (S/D) plasma is plasma pooled from many donors of the same ABO blood group, then treated with a solvent and a detergent. The treatment inactivates lipid-enveloped viruses such as HIV, hepatitis B, and hepatitis C. Pooling also averages out donor-to-donor variation in clotting factor levels.

In the United States, the licensed S/D plasma product is Octaplas, made by Octapharma. The FDA licensed Octaplas in 2013 as a biologic. It arrives as a manufactured product, not as a unit collected by the local blood center.

According to its FDA labeling, Octaplas is indicated for two uses.

• Replacement of multiple coagulation factors in patients with acquired deficiencies due to liver disease, or who are undergoing cardiac surgery or liver transplant.
• Plasma exchange in patients with thrombotic thrombocytopenic purpura (TTP).

Hospitals that stock S/D plasma are mostly transplant centers, cardiac surgery programs, and apheresis services. Some choose it for patients who need large plasma volumes, because pooling and viral inactivation change the product’s risk profile.

What does P9023 cover and exclude?

P9023 covers one product: frozen plasma that is pooled from multiple donors and solvent/detergent treated. The code applies whenever that product is thawed and administered, whatever the clinical indication.

These related products fall outside P9023 and take their own codes.

• Single-donor fresh frozen plasma frozen within 8 hours of collection is P9017, not P9023.
• Pooled pathogen-reduced plasma is P9070. Pathogen reduction is a different process from solvent/detergent treatment.
• Single-donor pathogen-reduced plasma is P9071.
• Cryoprecipitate is P9012, and cryoprecipitate-reduced plasma is P9044.
• Leukocyte-reduced red blood cells are P9016, a red cell product billed on its own line.
• Plasma derivatives such as albumin and plasma protein fraction have their own P-codes (P9041, P9043, P9045, P9046, P9047, and P9048).

Clinical procedure: how S/D plasma is administered and documented

Each step of the transfusion workflow produces a record that supports the P9023 line. A missing record is the easiest reason for a payer to question medical necessity.

1. Physician order. The order names the product, the number of units, and the clinical indication. It must be on file before the blood bank releases the product.
2. Blood bank release. The transfusion service issues the S/D plasma bag and records the product code, lot number, issue time, and recipient. This record ties the billed unit to a specific product.
3. Thawing. The bag is thawed and held according to the manufacturer’s labeling and the hospital’s transfusion policy. Thaw and issue times should match the administration record.
4. Administration. A nurse or clinician records start and stop times, vital signs, and any transfusion reaction. Each bag administered is one billable unit.
5. Post-transfusion monitoring. Follow-up labs such as PT, INR, or fibrinogen show the clinical response and support medical necessity on review.

How to bill HCPCS code P9023: units, revenue codes, and wastage

Report one unit of service for each bag of S/D plasma administered. If three bags are transfused, P9023 carries three units. Bill the units administered according to your MAC’s instructions.

On the UB-04, hospitals report blood products with a revenue code from the blood (038X) or blood processing and storage (039X) series. The choice is set out in Medicare Claims Processing Manual, Chapter 4, section 231, and your MAC’s billing guide confirms which applies.

The JW and JZ drug-wastage modifiers apply to single-dose drugs and biologicals billed with drug codes, not to P9 blood-product codes. When a thawed bag is not transfused, follow your MAC or payer instructions and your hospital’s blood wastage policy.

Medicare and payer reimbursement for P9023

Under the Medicare hospital outpatient prospective payment system (OPPS), P9023 carries status indicator R, which means blood and blood products paid separately through an APC. Look up the current payment rate in the CMS OPPS Addendum B for the quarter of service.

For inpatient stays, the product is part of the hospital’s inpatient payment rather than a separately paid line. Neither the Physician Fee Schedule nor the clinical laboratory fee schedule sets a rate for P9023.

The blood deductible does not apply to plasma

Medicare’s blood deductible covers the first three pints of blood a beneficiary receives each calendar year, under Part A and Part B combined. It applies only to whole blood and packed red cells, per Claims Processing Manual Chapter 4, section 231.

Plasma, including S/D plasma billed with P9023, is not subject to the blood deductible. The standard Part B deductible and coinsurance apply to an outpatient P9023 line instead.

Commercial payers

Commercial coverage and prior authorization rules vary. Some payers route outpatient blood products through a separate infusion benefit. Confirm the payer’s policy before a scheduled transfusion, such as planned plasma exchange, and record any authorization number on the claim.

ICD-10 diagnosis codes that can support a P9023 claim

Every P9023 claim needs a diagnosis that establishes medical necessity. The attending physician owns the diagnosis, and the billing team checks that the claim matches the documented indication.

The table below is illustrative, built around the FDA-labeled uses of S/D plasma. It is not a coverage list, so check your MAC and payer policies for the codes they accept.

Unspecified codes are acceptable when a specific diagnosis is not yet confirmed, but payers expect the most specific code the record supports. If the chart documents a confirmed diagnosis, code it.

Related HCPCS codes: P9023 vs P9017, P9070, P9071, P9044, and P9012

Among the Level II HCPCS codes, the plasma codes in the P9 range split on two questions. Is the product pooled from many donors or collected from one? And was it solvent/detergent treated, pathogen reduced, or neither? The chart below walks through both, starting with processing.

One frequent miscoding on this code is using P9023 as a catch-all for fresh frozen plasma. Standard single-donor FFP belongs on P9017. A unit held in quarantine until the donor was retested belongs on P9060. Another is confusing P9023 with P9070, because both are pooled. The processing line on the bag label decides between them.

Common claim denials for HCPCS code P9023 and how to avoid them

P9023 denials cluster around a few predictable errors. Our denial management process guide covers the general workflow: find the root cause, correct the record, and resubmit with support attached.

Documentation checklist for P9023 claims

This checklist maps each record to the denial it prevents. Review it before submitting a P9023 claim, especially for scheduled outpatient transfusions. Good medical billing compliance starts with documentation, not with the remittance advice.

• Physician order. Dated before the blood bank release, naming S/D plasma, the number of units, and the indication.
• Blood bank issue record. Shows the product code identifying solvent/detergent treated pooled plasma, the lot number, issue time, and recipient. This is the primary audit document for code and unit checks.
• Nursing infusion note. Records start and stop times, infusion rate, patient response, and any reaction for each unit. Timestamps should align with the blood bank record.
• Pre-transfusion labs. PT, INR, fibrinogen, or platelet counts showing the coagulopathy or TTP picture that justified the transfusion.
• Post-transfusion labs. Follow-up results confirming the clinical response, which matter most for repeat transfusions or plasma exchange series.
• Wastage record. If a thawed bag was not transfused, the blood bank records the unit and the reason, per hospital policy.
• Prior authorization number. Where a commercial payer requires it, the number appears on the claim and in the record.
• Patient consent. A signed transfusion consent per facility policy and state law.

How Pabau keeps blood product claim lines traceable

Most billing teams check a P9023 claim by opening three systems: the blood bank log, the nursing record, and the billing software. When a payer asks for support months later, someone rebuilds the trail by hand.

Pabau keeps clinical notes, charges, and invoices on one patient record. Its claims management software submits claims from that data and tracks their status through to payment or denial. Your team still confirms the code, units, and diagnosis, and Pabau keeps the notes and charges behind that decision on the same record.

The result is a shorter path from a payer’s records request to a complete response, because the documentation already sits next to the claim.

Keep blood product claims traceable with Pabau

Pabau keeps clinical documentation, charges, and claim status in one system. Billing teams can trace each P9023 line back to the record that supports it, and spend less time rebuilding evidence for a payer review.

Book a demo

Conclusion

P9023 is a narrow code. It fits one product, solvent/detergent treated pooled plasma, and the bag label is the fastest way to prove it. Practices that confirm the product code before billing avoid the two product mix-ups this code invites. One is FFP billed as P9023, and the other is P9070 confused with P9023.

After the code, the claim rests on units that match the release log and a diagnosis that matches the order. Payment runs through OPPS, and the blood deductible stays out of it. To see how Pabau keeps that documentation and the claim in one place, book a demo.

Continue your research

Need a framework for reducing claim rejections across your practice? Clean claim submission covers the elements every claim needs to pass payer edits before adjudication.

New to the revenue cycle behind a claim like this? What is medical billing explains the end-to-end revenue cycle from charge capture to payment posting.

Billing a plasma derivative instead? HCPCS code P9043 covers plasma protein fraction, which takes its own P-code rather than P9023.

Got a denial back on a blood product line? Denial codes in medical billing explains what the common denial codes mean and how to respond to them.

Frequently asked questions